Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
LUNG
$2.42
+12.04%
LUNG · Pulmonx Corp
$2.42
+0.26 (+12.04%)
At close · Aug 14
Market Cap
$103.93M
Shares
42.95M
All earnings calls
Earnings call · FY2026 Q2
Pulmonx Q2 2026 Earnings Conference Call
Pulmonx Q2 2026 Earnings Conference Call
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$22.76M
-4.6% YoY
Diluted EPS
-$0.24
Gross margin
78.0%
+5.9 pp YoY
Net income
-$10.08M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jul 29, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
full year 2026
|
$90M – $92M | — | |
|
Gross margin
full year 2026
|
at least 76% | — | |
|
Total operating expenses
full year 2026
|
$109M – $111M | — | |
|
Cash, cash equivalents, and marketable securities decrease
full year 2026
|
at least $-23M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 29, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 4, 2026 · complete as-filed document